These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21208226)

  • 1. Limited utility of exercise-stress testing to prevent T-wave oversensing in pediatric internal cardioverter defibrillator recipients.
    Cohen MI; Shaffer J; Pedersen S; Sims JJ; Papez A
    Pacing Clin Electrophysiol; 2011 Apr; 34(4):436-42. PubMed ID: 21208226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avoiding inappropriate ventricular tachycardia detection due to T-wave oversensing in an implantable cardioverter defibrillator: a novel application of the electrogram width criterion.
    Duru F; Bauersfeld U; Candinas R
    Europace; 2001 Jan; 3(1):80-4. PubMed ID: 11271957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-wave oversensing in implantable cardiac defibrillators is due to technical failure of device sensing.
    Gilliam FR
    J Cardiovasc Electrophysiol; 2006 May; 17(5):553-6. PubMed ID: 16684033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fully automatic, implantable cardioverter-defibrillator algorithm to prevent inappropriate detection of ventricular tachycardia or fibrillation due to T-wave oversensing in spontaneous rhythm.
    Cao J; Gillberg JM; Swerdlow CD
    Heart Rhythm; 2012 Apr; 9(4):522-30. PubMed ID: 22094074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
    Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of exercise electrocardiogram to screen for T-wave oversensing after implantation of subcutaneous implantable cardioverter-defibrillator.
    Afzal MR; Evenson C; Badin A; Patel D; Godara H; Essandoh M; Okabe T; Tyler J; Houmsse M; Augostini R; Hummel J; Kalbfleisch S; Daoud EG; Weiss R
    Heart Rhythm; 2017 Oct; 14(10):1436-1439. PubMed ID: 28624663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolution of T-wave oversensing with implantable cardioverter defibrillator generator replacement in an adolescent.
    Tuzcu V
    Pacing Clin Electrophysiol; 2007 Jul; 30(7):929-32. PubMed ID: 17584279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An algorithm to predict implantable cardioverter-defibrillator lead failure.
    Gunderson BD; Patel AS; Bounds CA; Shepard RK; Wood MA; Ellenbogen KA
    J Am Coll Cardiol; 2004 Nov; 44(9):1898-902. PubMed ID: 15519026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Death due to an implantable cardioverter defibrillator.
    Messali A; Thomas O; Chauvin M; Coumel P; Leenhardt A
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):953-6. PubMed ID: 15333095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management.
    Kooiman KM; Knops RE; Olde Nordkamp L; Wilde AA; de Groot JR
    Heart Rhythm; 2014 Mar; 11(3):426-34. PubMed ID: 24321235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The power of exercise-induced T-wave alternans to predict ventricular arrhythmias in patients with implanted cardiac defibrillator.
    Burattini L; Man S; Sweene CA
    J Healthc Eng; 2013; 4(2):167-84. PubMed ID: 23778010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-wave oversensing and inappropriate shocks: a case report.
    Srivathsan K; Scott LR; Altemose GT
    Europace; 2008 May; 10(5):552-5. PubMed ID: 18442965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy -- dilemmas and difficulties.
    Przybylski A; Małecka L; Pytkowski M; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Ruzyłło W; Szwed H
    Kardiol Pol; 2005 Oct; 63(4):391-7; discussion 398. PubMed ID: 16273479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lability of R- and T-wave peaks in three-dimensional electrocardiograms in implantable cardioverter defibrillator patients with ventricular tachyarrhythmia during follow-up.
    Han L; Tereshchenko LG
    J Electrocardiol; 2010; 43(6):577-82. PubMed ID: 20655057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular oversensing after replacement of an implantable cardioverter-defibrillator.
    Arias MA; Puchol A; Castellanos E; Pachón M; Rodríguez-Padial L
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):925-7. PubMed ID: 19572871
    [No Abstract]   [Full Text] [Related]  

  • 17. T wave oversensing by a cardioverter defibrillator implanted in a patient with the Brugada syndrome.
    Porres JM; Brugada J; Marco P; García F; Azcarate B
    Pacing Clin Electrophysiol; 2004 Nov; 27(11):1563-5. PubMed ID: 15546314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial inhibition of ongoing antitachycardia pacing sequence due to T-wave oversensing.
    Manolis AG; Chatzis DG; Kouvelas K; Kyriakides ZS
    Pacing Clin Electrophysiol; 2008 Jun; 31(6):780-1. PubMed ID: 18507556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial.
    Chow T; Kereiakes DJ; Onufer J; Woelfel A; Gursoy S; Peterson BJ; Brown ML; Pu W; Benditt DG;
    J Am Coll Cardiol; 2008 Nov; 52(20):1607-15. PubMed ID: 18992649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.